2021
DOI: 10.1016/j.crad.2020.08.019
|View full text |Cite
|
Sign up to set email alerts
|

Global longitudinal diastolic strain rate as a novel marker for predicting adverse outcomes in hypertrophic cardiomyopathy by cardiac magnetic resonance tissue tracking

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
10
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 13 publications
(10 citation statements)
references
References 19 publications
0
10
0
Order By: Relevance
“…The dysfunction of the LV in HCM is silent, and given myocardial contraction is heterogeneous, the different markers of strain assessment are useful in delineating the type of contractile dysfunction. For instance, the hypertrophied segments often exhibit reduced early diastolic strain rates [ 53 ]. Such aggravation in myocardial integrity correlates biochemically, with elevated NT-proBNP and troponin T, and is also reflected by an increased likelihood of ventricular arrhythmias [ 18 , 54 ].…”
Section: Resultsmentioning
confidence: 99%
“…The dysfunction of the LV in HCM is silent, and given myocardial contraction is heterogeneous, the different markers of strain assessment are useful in delineating the type of contractile dysfunction. For instance, the hypertrophied segments often exhibit reduced early diastolic strain rates [ 53 ]. Such aggravation in myocardial integrity correlates biochemically, with elevated NT-proBNP and troponin T, and is also reflected by an increased likelihood of ventricular arrhythmias [ 18 , 54 ].…”
Section: Resultsmentioning
confidence: 99%
“…The use of CMR-FT to evaluate LV diastolic impairment has already been performed in asymptomatic patients with BAV and preserved ejection fraction [ 14 ], evidencing an alteration in diastolic strain parameters in BAV subjects as compared to control groups [ 14 ]. Other studies revealed that CMR-FT myocardial diastolic strain analysis was able to predict adverse outcomes in patients with hypertrophic cardiomyopathy or atherosclerosis [ 28 , 29 ].…”
Section: Discussionmentioning
confidence: 99%
“…Adverse events that occurred after PVR surgery were recorded. Adverse events included sudden cardiac death (unexpected death either within 1 h of the onset of cardiac symptoms without progressive cardiac deterioration, when asleep, or within 24 h of last being seen alive) ( 17 ), cardiac transplantation, application of implantable cardioverter defibrillator (ICD) ( 18 ), heart failure ( 19 ), and arrhythmia-induced syncope (“syncope caused by arrhythmias” was adjudicated based on clinical symptom and ECG monitor). The syncope cases were defined position-independent, with few prodromal symptoms, and may occur with cyanosis, dyspnea, arrhythmias, weak heart sounds, and associated ECG-detected arrhythmias) ( 20 , 21 ), reoperation for PVR, sustained atrial or ventricular arrhythmias analyzed by 24-h Holter monitoring (last ≥ 30s but not causing syncope), and cardiac catheterization ablation ( 22 ).…”
Section: Methodsmentioning
confidence: 99%